Conghua Xie (C Xie)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 63

Top Venues

Immunotherapy

PloS one

Journal of translational medicine

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mei Qu, Zhiliang Jin, Yanhua Xu, Wenjie Sun, Yuan Luo, Nannan Zhang, Zhengrong Huang, Linzhi Han, Yan Gong, Conghua Xie
hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox. Genetic testing and molecular biomarkers 27 (12) (2024)
Gen Lin, Zhijie Wang, Qian Chu, Yi Hu, Dingzhi Huang, Jun Wang, Fan Yang, Wen-Zhao Zhong, Cheng-Zhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Daun, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Cheng-Bo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si-Yang Maggie Liu, Liu Yutao, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tang-Feng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wen-Xian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chun-Wei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tong-Mei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Qiaofeng Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer (2024)
Cheng Chen, Nandi Chen, Yan Qi, Meng Lyu, Chaoyan Wu, Conghua Xie, Hai-Jun Yu
Copper-Based Single-Atom Nanozyme System Mimicking Platelet Cells for Enhancing the Outcome of Radioimmunotherapy. International journal of nanomedicine 19 (2024)
Cheng Chen, Nandi Chen, Yan Qi, Meng Lyu, Chaoyan Wu, Conghua Xie, Hai-Jun Yu
Copper-Based Single-Atom Nanozyme System Mimicking Platelet Cells for Enhancing the Outcome of Radioimmunotherapy. International journal of nanomedicine 19 (2024)
Mei Qu, Zhiliang Jin, Yanhua Xu, Wenjie Sun, Yuan Luo, Nannan Zhang, Zhengrong Huang, Linzhi Han, Yan Gong, Conghua Xie
hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox. Genetic testing and molecular biomarkers 27 (12) (2024)
Gen Lin, Zhijie Wang, Qian Chu, Yi Hu, Dingzhi Huang, Jun Wang, Fan Yang, Wen-Zhao Zhong, Cheng-Zhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Daun, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Cheng-Bo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si-Yang Maggie Liu, Liu Yutao, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tang-Feng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wen-Xian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chun-Wei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tong-Mei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Qiaofeng Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (5) (2024)
Gen Lin, Zhijie Wang, Qian Chu, Yi Hu, Dingzhi Huang, Jun Wang, Fan Yang, Wen-Zhao Zhong, Cheng-Zhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Daun, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Cheng-Bo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si-Yang Maggie Liu, Liu Yutao, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tang-Feng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wen-Xian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chun-Wei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tong-Mei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Qiaofeng Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (5) (2024)
Gen Lin, Zhijie Wang, Qian Chu, Yi Hu, Dingzhi Huang, Jun Wang, Fan Yang, Wen-Zhao Zhong, Cheng-Zhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Daun, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Cheng-Bo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si-Yang Maggie Liu, Liu Yutao, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tang-Feng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wen-Xian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chun-Wei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tong-Mei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Qiaofeng Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 15 (5) (2024)
Yajie Cheng, Wen Ouyang, Chen Jie, Junhong Zhang, Conghua Xie, Conghua Xie
A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy 15 (2) (2023)
Yajie Cheng, Wen Ouyang, Chen Jie, Junhong Zhang, Conghua Xie, Conghua Xie
A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy (2023)
Yajie Cheng, Wen Ouyang, Chen Jie, Junhong Zhang, Conghua Xie, Conghua Xie
A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy 15 (2) (2023)
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Wei Dong, Yan Gong, Conghua Xie
Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis. The oncologist (2023)
Wei Zhang, Min Chen, Qingming Xiang, Shaoxing Sun, Hong Cao, Conghua Xie, Hui Qiu
Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer: a case report. Immunotherapy (2023)
Xiangling Xiao, Jie Shi, Chuan He, Xia Bu, Yishuang Sun, Minling Gao, Bolin Xiang, Wenjun Xiong, Panpan Dai, Qi Mao, Xixin Xing, Yingmeng Yao, Haisheng Yu, Gaoshan Xu, Siqi Li, Yan Ren, Baoxiang Chen, Congqing Jiang, Geng Meng, Yu-Ru Lee, Wenyi Wei, Gordon J Freeman, Conghua Xie, Jinfang Zhang
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nature communications 14 (1) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Xiangling Xiao, Jie Shi, Chuan He, Xia Bu, Yishuang Sun, Minling Gao, Bolin Xiang, Wenjun Xiong, Panpan Dai, Qi Mao, Xixin Xing, Yingmeng Yao, Haisheng Yu, Gaoshan Xu, Siqi Li, Yan Ren, Baoxiang Chen, Congqing Jiang, Geng Meng, Yu-Ru Lee, Wenyi Wei, Gordon J Freeman, Conghua Xie, Jinfang Zhang
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nature communications 14 (1) (2023)
Dingzhi Huang, Gen Lin, Qian Chu, Yi Hu, Jun Wang, Zhijie Wang, Fan Yang, Wen-Zhao Zhong, Cheng-Zhi Zhou, Bo Zhu, Xinghao Ai, Baoshan Cao, Yabing Cao, Mingqiu Chen, Xiaohui Chen, Tianqing Chu, Jianchun Daun, Yun Fan, Yong Fang, Shuitu Feng, Weineng Feng, Hui Guo, Cheng-Bo Han, Yong He, Shaodong Hong, Jie Hu, Meijuan Huang, Yan Huang, Da Jiang, Kan Jiang, Richeng Jiang, Bo Jin, Shi Jin, Jisheng Li, Min Li, Ziming Li, Chao Li, Jie Lin, Anwen Liu, Si-Yang Maggie Liu, Yutao Liu, Zhefeng Liu, Zhe Liu, Zhenhua Liu, Zhentian Liu, Zhigang Liu, Yuping Lu, Tang-Feng Lv, Zhiyong Ma, Qian Miao, Min Peng, Xingxiang Pu, Xiu Bao Ren, Jianzhen Shan, Jinlu Shan, Peng Shen, Bo Shen, Meiqi Shi, Yong Song, Zhengbo Song, ChunXia Su, Jianguo Sun, Panwen Tian, Jinliang Wang, Feng Wang, Huijuan Wang, Jialei Wang, Qian Wang, Wen-Xian Wang, Yan Wang, Lin Wu, Fang Wu, Yang Xia, Congying Xie, Conghua Xie, Tao Xin, Jianping Xiong, Haipeng Xu, Song Xu, Yiquan Xu, Bin Xu, Chun-Wei Xu, Xiaolong Yan, Zhenzhou Yang, Wenxiu Yao, Yao Yu, Ye Feng, Zongyang Yu, Yongfeng Yu, Dongsheng Yue, Haibo Zhang, HongMei Zhang, Li Zhang, Longfeng Zhang, Qiuyu Zhang, Tong-Mei Zhang, Bicheng Zhang, Jun Zhao, Mingfang Zhao, Xiaobin Zheng, Fengqiao Zhong, Jin Zhou, Penghui Zhou, Zhengfei Zhu, Juntao Zou, Zihua Zou
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer. Thoracic cancer (2023)
Yajie Cheng, Wen Ouyang, Chen Jie, Junhong Zhang, Conghua Xie, Conghua Xie
A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy 15 (2) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Xiangling Xiao, Jie Shi, Chuan He, Xia Bu, Yishuang Sun, Minling Gao, Bolin Xiang, Wenjun Xiong, Panpan Dai, Qi Mao, Xixin Xing, Yingmeng Yao, Haisheng Yu, Gaoshan Xu, Siqi Li, Yan Ren, Baoxiang Chen, Congqing Jiang, Geng Meng, Yu-Ru Lee, Wenyi Wei, Gordon J Freeman, Conghua Xie, Jinfang Zhang
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nature communications 14 (1) (2023)
Yan Zhu, Wenjie Sun, Xueping Jiang, Rui Bai, Yuan Luo, Yanping Gao, Shuying Li, Zhengrong Huang, Yan Gong, Conghua Xie
Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors. PloS one 18 (1) (2023)
Yajie Cheng, Wen Ouyang, Chen Jie, Junhong Zhang, Conghua Xie, Conghua Xie
A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma. Immunotherapy 15 (2) (2023)
Yangyi Li, Yuke Gao, Xueping Jiang, Yajie Cheng, Jianguo Zhang, Liexi Xu, Xinyu Liu, Zhengrong Huang, Conghua Xie, Yan Gong
SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma. Journal of translational medicine 20 (1) (2022)
Hongxin Xie, Xinyu Liu, Zhengrong Huang, Liexi Xu, Rui Bai, Fajian He, Mengqin Wang, Linzhi Han, Zhirong Bao, Yuzhou Wu, Conghua Xie, Yan Gong
Nanoscale Zeolitic Imidazolate Framework (ZIF)-8 in Cancer Theranostics: Current Challenges and Prospects. Cancers 14 (16) (2022)
Jiarui Chen, Xingyu Liu, Junhong Zhang, Zhao Huang, Wei Zeng, Jing Hu, Gang Chen, Yan Gong, Yu Liu, Conghua Xie
Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small-cell lung cancer: a network meta-analysis. Future oncology (London, England) 18 (13) (2022)
Yangyi Li, Yuke Gao, Xueping Jiang, Yajie Cheng, Jianguo Zhang, Liexi Xu, Xinyu Liu, Zhengrong Huang, Conghua Xie, Yan Gong
SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma. Journal of translational medicine 20 (1) (2022)
Jia-Li Li, Zi-Hang Zeng, Zhengrong Huang, Yan Gong, Conghua Xie
Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I-IIA Small Cell Lung Cancer: Analysis of the SEER Database. Journal of oncology 2022 (2022)
Wenjun Xiong, Xueliang Gao, Tiantian Zhang, Baishan Jiang, Ming-Ming Hu, Xia Bu, Yang Gao, Lin-Zhou Zhang, Bo-Lin Xiao, Chuan He, Yishuang Sun, Haiou Li, Jie Shi, Xiangling Xiao, Bolin Xiang, Conghua Xie, Gang Chen, Haojian Zhang, Wenyi Wei, Gordon J Freeman, Hong-Bing Shu, Haizhen Wang, Jinfang Zhang
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nature communications 13 (1) (2022)
Sisi Yang, Ziwen Tang, Yilong Tian, Xinghu Ji, Fubing Wang, Conghua Xie, Zhike He
Dual-Color Fluorescent Hydrogel Microspheres Combined with Smartphones for Visual Detection of Lactate. Biosensors 12 (10) (2022)
Yangyi Li, Yuke Gao, Xueping Jiang, Yajie Cheng, Jianguo Zhang, Liexi Xu, Xinyu Liu, Zhengrong Huang, Conghua Xie, Yan Gong
SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma. Journal of translational medicine 20 (1) (2022)
Xueping Jiang, Yangyi Li, Nannan Zhang, Yanping Gao, Linzhi Han, Shuying Li, Jiali Li, Xingyu Liu, Yan Gong, Conghua Xie
Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma. Cell & bioscience 12 (1) (2022)
Jun Xiong, Ping Wang, Wen-Xuan Shao, Gaojie Li, Jiang-Hui Ding, Neng-Bin Xie, Min Wang, Qing-Yun Cheng, Conghua Xie, Bi-Feng Yuan, Weimin Ci, Bi-Feng Yuan
Genome-wide mapping of N 4 -methylcytosine at single-base resolution by APOBEC3A-mediated deamination sequencing. Chemical science 13 (34) (2022)
Yanping Gao, Nannan Zhang, Zihang Zeng, Qiuji Wu, Xueping Jiang, Shuying Li, Wenjie Sun, Jianguo Zhang, Yangyi Li, Jiali Li, Fajian He, Zhengrong Huang, Jinfang Zhang, Yan Gong, Conghua Xie
LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer. Clinical and translational medicine 12 (4) (2022)
Yuke Gao, Yangyi Li, Zaihuan Lin, Yuxin Zeng, Zhengrong Huang, Linzhi Han, Yahua Zhong, Yan Gong, Qiuji Wu, Conghua Xie
Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway. Immunology (2022)
Xinyu Liu, Meron Tsegay Kifle, Hongxin Xie, Liexi Xu, Maoling Luo, Yangyi Li, Zhengrong Huang, Yan Gong, Yuzhou Wu, Conghua Xie
Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer. Nanomaterials (Basel, Switzerland) 12 (18) (2022)
Rui Bai, Jianguo Zhang, Fajian He, Yangyi Li, Panpan Dai, Zhengrong Huang, Linzhi Han, Zhihao Wang, Yan Gong, Conghua Xie
GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma. Communications biology 5 (1) (2022)
Yangyi Li, Yuke Gao, Xueping Jiang, Yajie Cheng, Jianguo Zhang, Liexi Xu, Xinyu Liu, Zhengrong Huang, Conghua Xie, Yan Gong
SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma. Journal of translational medicine 20 (1) (2022)
Jiarui Chen, Xingyu Liu, Qiuji Wu, Xueping Jiang, Zihang Zeng, Jiali Li, Yanping Gao, Yan Gong, Conghua Xie
Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma. Cell transplantation 30 (2022)
Shuting Han, Qingyuan Zhuang, Jianbang Chiang, Sze Huey Tan, Gail Wan Ying Chua, Conghua Xie, Matthew Chin Heng Chua, Yu Yang Soon, Valerie Shiwen Yang
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ open 12 (2) (2022)
Xueping Jiang, Yanping Gao, Nannan Zhang, Cheng Yuan, Yuan Luo, Wenjie Sun, Jianguo Zhang, Jiangbo Ren, Yan Gong, Conghua Xie
Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis. Cell transplantation 29 (2021)
Xueping Jiang, Yangyi Li, Nannan Zhang, Yanping Gao, Linzhi Han, Shuying Li, Jiali Li, Xingyu Liu, Yan Gong, Conghua Xie
RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma. Cell & bioscience 11 (1) (2021)
Zihang Zeng, Jiali Li, Jianguo Zhang, Yangyi Li, Xingyu Liu, Jiarui Chen, Zhengrong Huang, Qiuji Wu, Yan Gong, Conghua Xie
Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis. Journal of translational medicine 19 (1) (2021)
Wenjie Sun, Shuying Li, Guiliang Tang, Shaoxing Sun, Yuan Luo, Rui Bai, Linzhi Han, Xueping Jiang, Yanping Gao, Zhengrong Huang, Junhong Zhang, Yan Gong, Conghua Xie
HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization. Cancer medicine 10 (15) (2021)
Qingzhu Jia, Qian Chu, Anmei Zhang, Jing Yu, Fangfang Liu, Kaiyu Qian, Yu Xiao, Xue Wang, Ying Yang, Yi Zhao, Ji He, Guanghui Li, Yisong Y Wan, Conghua Xie, Bo Zhu
Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer. Communications biology 4 (1) (2021)
Hui Yang, Min Chen, Zijie Mei, Conghua Xie, Yunfeng Zhou, Hui Qiu
Effectiveness and prognostic factors of apatinib treatment in patients with recurrent or advanced cervical carcinoma: A retrospective study. Cancer medicine 10 (13) (2021)
Shuying Li, Wenjie Sun, Yuan Luo, Yanping Gao, Xueping Jiang, Cheng Yuan, Linzhi Han, Kuo Cao, Yan Gong, Conghua Xie
Hollow PtCo alloy nanospheres as a high-Z and oxygen generating nanozyme for radiotherapy enhancement in non-small cell lung cancer. Journal of materials chemistry. B 9 (23) (2021)
N Zhang, Y Gao, Z Zeng, Y Luo, X Jiang, J Zhang, J Li, J Zhang, Y Gong, Conghua Xie
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (9) (2021)
Shaodong Hong, Ya-Xiong Zhang, Gengsheng Yu, Peijian Peng, Jiewen Peng, Jun Jia, Xuan Wu, Yan Huang, Yunpeng Yang, Qing Lin, Xuping Xi, Mingjun Xu, Dongping Chen, Xiaojun Lu, Ren-Sheng Wang, Xiaolong Cao, Xiaozhong Chen, Zhixiong Lin, Jianping Xiong, Qin Lin, Conghua Xie, Zhihua Li, Jianji Pan, Jingao Li, Shixiu Wu, Yingni Lian, Quanlie Yang, Chong Zhao, Wenfeng Fang, Li Zhang
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
Cheng Yuan, Rui Bai, Yanping Gao, Xueping Jiang, Shuying Li, Wenjie Sun, Yangyi Li, Zhengrong Huang, Yan Gong, Conghua Xie
Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10. Oxidative medicine and cellular longevity 2021 (2021)
Qiuji Wu, Hongyan Zhang, Yahua Zhong, Matthew Chin Heng Chua, Conghua Xie
Reply to Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance? Cancer 127 (6) (2021)
Hui Yang, Shaoxing Sun, Zijie Mei, Qingming Xiang, Chunxu Yang, Min Chen, Conghua Xie, Yunfeng Zhou, Hui Qiu
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy. Drug design, development and therapy 15 (2021)
Jianguo Zhang, Jianzhong Zhang, Cheng Yuan, Yuan Luo, Yangyi Li, Panpan Dai, Wenjie Sun, Nannan Zhang, Jiangbo Ren, Junhong Zhang, Yan Gong, Conghua Xie
Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis. Cancer cell international 20 (2020)
Qiuji Wu, Qian Chu, Hongyan Zhang, Bin Yang, Xudong He, Yahua Zhong, Xianglin Yuan, Melvin L K Chua, Conghua Xie
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors. Cancer communications (London, England) 40 (8) (2020)
Linzhi Han, Hongjie Shi, Yuan Luo, Wenjie Sun, Shuying Li, Nannan Zhang, Xueping Jiang, Yan Gong, Conghua Xie
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma. Cancer medicine 9 (24) (2020)
Yanhong Cen, Zhao Huang, Jiangbo Ren, Junhong Zhang, Yan Gong, Conghua Xie
The characteristic of tumor immune microenvironment in pulmonary carcinosarcoma. Immunotherapy 12 (5) (2020)
Hongyan Zhang, Linwei Wang, Yuanyuan Chen, Qiuji Wu, Gaili Chen, Xiaokun Shen, Qun Wang, Youqin Yan, Yi Yu, Yahua Zhong, Xinghuan Wang, Matthew Chin Heng Chua, Conghua Xie
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China. Cancer 126 (17) (2020)
Wenjie Sun, Shuying Li, Guiliang Tang, Yuan Luo, Shijing Ma, Shaoxing Sun, Jiangbo Ren, Yan Gong, Conghua Xie
Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application. International journal of nanomedicine 14 (2019)
Hui Xie, Conghua Xie
A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network. BioMed research international 2019 (2019)
Conghua Xie, Wen Ouyang, Yi Li, Jing Hu, Yu Xu, Yongchang Wei, Zhengkai Liao, Yu Liu, Junhong Zhang, Conghua Xie
Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database. Cancer medicine 8 (1) (2018)
Qingxuan Hu, Gang Wang, Jianping Peng, Guofeng Qian, Wei Jiang, Conghua Xie, Yu Xiao, Xing-Huan Wang
Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways. BioMed research international 2017 (2017)

Conghua Xie.css-eqlu8i{font-size:small;padding-left:4px;} (C Xie)

Publication Activity (10 Years)

Top Topics

Top Venues

Conghua Xie (C Xie)